An official website of the United States government
Home
SEER Inquiry System - Report
Produced: 06/07/2023 8:51 PM
Question 20190016
Inquiry Details
References:
#1: 2018 Summary Stage. Breast
#2: 2018 EOD Manual. Breast
Question:
Update to current manual/SS2018--Breast: Should Code 3 of the Summary Stage 2018 (SS2018) for Breast designate the intramammary and infraclavicular lymph nodes as being ipsilateral? Similarly, should Code 7 designate infraclavicular lymph nodes as contralateral/bilateral? Laterality (ipsilateral, contralateral/bilateral) is included for axillary and internal mammary nodes in the respective codes.
Discussion:
Answer:
Based on your question, a review of the AJCC manual was done to clarify how these nodes would be coded. A review of Extent of Disease (EOD) Regional Nodes and EOD Mets was also done. That information is correct and in line with AJCC 8th edition. We apologize that SS2018 was not updated accordingly and thank you for bringing this issue to our attention.
Per AJCC, infraclavicular and intramammary nodes are ipsilateral for the N category. Contralateral or bilateral involvement are included in the M category.
The following will be applied to the planned 2020 update of the SS2018 manual.
Code 3
Ipsilateral will be added to Infraclavicular and Intramammary
Infraclavicular (subclavicular) (ipsilateral)
Intramammary (ipsilateral)
Code 7
The following will be added under Distant lymph nodes
Infraclavicular (subclavicular) (contralateral or bilateral)
Intramammary (contralateral or bilateral)
